Inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a top plan view of an inhaler showing my new design;
FIG. 2 is a side elevation view showing the right side thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front view thereof;
FIG. 6 is a perspective view showing the top, rear and left side thereof; and,
FIG. 7 is a perspective view showing the new design in an open position.
Referenced Cited
Patent History
Patent number: D379506
Type: Grant
Filed: Dec 29, 1995
Date of Patent: May 27, 1997
Assignee: Glaxo Group Limited (London)
Inventor: Joan Maher (Dundrum)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: I. Simmons
Law Firm: Bacon & Thomas
Application Number: 0/48,476
Type: Grant
Filed: Dec 29, 1995
Date of Patent: May 27, 1997
Assignee: Glaxo Group Limited (London)
Inventor: Joan Maher (Dundrum)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: I. Simmons
Law Firm: Bacon & Thomas
Application Number: 0/48,476
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2402;
International Classification: 2402;